Accendra Health (ACH) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Exagen (XGN) has outperformed Accendra Health (ACH) over the past year, losing 25.6% versus a loss of 90.6%. Over five years, XGN leads with a -35.3% price change compared with -98.7% for ACH. Exagen is the larger company by market cap ($197.9 million vs $34.1 million), about 5.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | XGN |
|---|---|---|
| Share price | $0.4432 | $8.17 |
| Market cap | $34.08M | $197.92M |
| 1-day change | -6.28% | -1.57% |
| YTD return | -84.17% | +34.38% |
| 1-year return | -90.61% | -25.59% |
| 5-year return | -98.65% | -35.31% |
| Forward P/E | 4.86 | — |
| EPS (TTM) | $-1.44 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $12.23 |
| 52-week low | $0.435 | $2.59 |
| Distance from 52-week high | -92.09% | -33.20% |
| Analyst consensus | hold | none |
| Avg. price target upside | +240.70% | +24.11% |
| Average volume | 1.41M | 328.42K |
| Shares outstanding | 76.90M | 24.23M |
| Employees | 6,500 | 216 |
| Sector | Healthcare | Health Care |
| Industry | Medical Distribution | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Exagen is about 5.8 times larger than Accendra Health by market value ($197.92M vs $34.08M).
- XGN has outperformed ACH by 65.0 percentage points over the past year.
- The two companies sit in different sectors: Accendra Health in Healthcare and Exagen in Health Care.
About Accendra Health
ACH stock →Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.
Healthcare · Medical Distribution · 6,500 employees
About Exagen
XGN stock →Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Health Care · Medical Specialities · 216 employees
ACH vs XGN FAQ
Which is bigger, Accendra Health or Exagen?
Exagen (XGN) is larger, with a market capitalization of $197.92M compared with $34.08M for Accendra Health (ACH).
Which stock has performed better over the past year, ACH or XGN?
XGN returned -25.59% over the past 12 months, compared with -90.61% for ACH (price return, excluding dividends). Past performance does not predict future results.
Are Accendra Health and Exagen in the same industry?
No. Accendra Health is in the Healthcare sector, while Exagen is in Health Care.